Chemomab Therapeutics Ltd ADR (CMMB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Operating Expenses | 5,972 | 22,898 | 13,035 | 9,392 | 4,642 |
| Operating Income | -5,972 | -22,898 | -13,035 | -9,392 | -4,642 |
| Interest Expense | -21 | 0 | 457 | 92 | 7 |
| Other Income | 0 | -4,226 | 0 | 1 | 44 |
| Pre-tax Income | -5,951 | -27,124 | -13,492 | -9,483 | -4,605 |
| Income Tax | N/A | N/A | 306 | 323 | 137 |
| Net Income Continuous | -5,951 | -27,124 | -13,798 | -9,806 | -4,742 |
| Net Income | $-5,951 | $-27,124 | $-13,798 | $-9,806 | $-4,742 |
| EPS Basic Total Ops | -3.52 | -251.97 | -348.80 | -348.80 | -278.40 |
| EPS Basic Continuous Ops | -3.48 | -251.99 | -349.45 | -347.69 | -279.20 |
| EPS Diluted Total Ops | -3.52 | -251.97 | -348.80 | -348.80 | -278.40 |
| EPS Diluted Continuous Ops | -3.48 | -251.99 | -349.45 | -347.69 | -279.20 |
| EPS Diluted Before Non-Recurring Items | -94.72 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-5,948 | $-22,617 | $-12,969 | $-9,341 | $-4,601 |